Autoimmune And Rheumatic Diseases
Patients with COVID-19 have 43% increased risk for new-onset autoimmune diseases
Patients with COVID-19 demonstrate a 43% increased risk for new-onset autoimmune diseases in the 3 to 15 months following acute infection, according to data published in Clinical Rheumatology.
The Congress of Clinical Rheumatology-West goes ‘Back to the Future’ in San Diego
Highlights of the upcoming 2023 Congress of Clinical Rheumatology-West include a talk on what the rheumatology field will look like in a decade, according to David A. McLain, MD, symposium director for the meeting.
Small study, seismic implications: Exploring the promise, challenges of CAR T in lupus
It is not often that a single data set has the potential to fundamentally alter the treatment landscape for a disease in rheumatology, but recent findings on the use of chimeric antigen receptor T-cells in lupus may eventually do just that.
‘Superwoman,’ ‘Cinderella’ narratives fail to empower women in medicine
Portraying professional women as superheroes who “do it all” can foster a narrative that can hold them back from career advancement, according to a presenter at the 2023 AWIR annual conference.
AWIR political advocacy arm claims state legislative victories in step therapy, PBM reform
From combatting step therapy to pharmacy benefit manager reform, the advocacy arm of the Association of Women in Rheumatology claimed several legislative victories in the past year, said presenters at the 2023 AWIR annual conference.
Improving workforce equity, addressing racism will require ‘transparency across the board’
True progress in achieving a diverse and equitable rheumatology workforce will require honest conversations regarding the impacts of racism and bias, according to a presenter at the 2023 AWIR annual conference.
Patients with multiple autoimmune diseases may improve from targeting shared pathways
Patients with multiple diseases that share immunologic pathways may benefit from therapies that target those shared pathways, but additional studies are needed in this area, according to a presenter at the 2023 AWIR annual conference.
Rheumatology, pulmonology must support each other in managing interstitial lung disease
AUSTIN, Texas — Ongoing communication between rheumatology and pulmonology is essential to managing “unpredictable” interstitial lung disease, according to a presenter at the 2023 Rheumatology Nurses Society annual conference.
‘We are not asking the right questions’: Social health determinants key in rheumatology
AUSTIN, Texas — Asking patients about their socioeconomic barriers to care can help rheumatology providers improve treatment outcomes, according to a presenter at the 2023 Rheumatology Nurses Society annual conference.
‘If you’re not at the table, you’re on the menu’: Political advocacy critical for nurses
AUSTIN, Texas — Rheumatology nurses can be effective advocates for legislation that will benefit patients despite the fractured U.S. political climate, according to a presenter at the 2023 Rheumatology Nurses Society annual conference.